Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV businessPoint-of-Care product revenue ...

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to ...

Investing.com -- Geopolitical tensions remain to the fore, while earnings and U.S. retail sales data will give an insight into the health of the consumer. Federal Reserve Chairman Jerome Powell is ...

Among those that increased their exposure to the cryptocurrency was Israel Englander's Millennium, which more than doubled ...

Which is the best company to work for in the Asia-Pacific region? Many, if not most, executives might claim that theirs is — ...

Rapid7 Inc Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Stockholders To Reach Out ...

Mumbai: The mornings have been providing some comfort, but the daytime heat has remained quite elevated. On Wednesday, the ...

Locked into a one-possession game at halftime, Colleyville Heritage had a chance to make some noise against a defending state champion. However, a pair of fourth-down conversions early in the second ...

Providing a diverse range of perspectives from bullish to bearish, 20 analysts have published ratings on FedEx FDX in the ...

Wall Street stocks delivered a mixed performance on Wednesday as market participants digested fresh inflation data.

Members of the Brownstoners of Bedford-Stuyvesant hold a house tour once a year to show off the culture and history of the Black home aesthetic. By Nicole A. Taylor A family needed more space ...